|
|
DSpace at RU >
University Library >
Academic bibliography >
Files in This Item:
| File |
Description |
Size | Format |
| publisher's version | 146.18 kB | Adobe PDF | Under Embargo
|
|
| Title: | Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donors. |
| Author(s): | Schattenberg, A.V.M.B. (104035919) Meer, A. van der (194575209) Preijers, F.W.M.B. (07401112X) Schaap, N.P.M. (243161697) Rinkes, M.J. (190743476) Maazen, R.W.M. van der (110288629) Allebes, W.A. (074327356) Joosten, I. (075051877) Witte, T.J.M. de (069336474) |
| Publication year: | 2004 |
| Document type: | Article / Letter to editor |
| Journal: | Bone Marrow Transplantation |
| ISSN: | 0268-3369 |
| Volume: | vol. 33 |
| Issue: | iss. 11 |
| Start page: | p. 1115 |
| End page: | p. 1121 |
| Abstract: | We retrospectively analysed the outcome of voluntary unrelated donor (VUD)-SCT in 56 patients after conditioning without or with ATG. All received partially lymphocyte-depleted grafts. Four of 17 patients (24%) who were not given ATG rejected their grafts, as did one of 33 (3%) conditioned with ATG (P=0.02). The incidences of acute graft-versus-host disease grade III/IV were 29 and 6%, respectively (P=0.02), and probabilities of 1-year transplant-related mortality were 64% (95% CI, 44-84%) and 27% (95% CI, 12-42%), respectively (P=0.004). Projected at 3 years, probability of survival was 18% (95% CI, 2-34%) after conditioning without ATG and 60% (95% CI, 43-70%) after conditioning with ATG (P=0.002). Probabilities of disease-free survival (DFS) were 18% (95% CI, 2-34%) and 45% (95% CI, 27-63%), respectively (P=0.005). Patients who did not receive ATG had a probability of current DFS of 18% (95% CI, 3-34%) and this was 60% (95% CI, 43-77%) for the patients conditioned with ATG (P<0.001). We conclude that the addition of ATG to the conditioning regimen is associated with a significantly more favourable outcome in recipients of partially T-cell-depleted grafts from VUDs. |
| Subject: | UMCN 1.2: Molecular diagnosis, prognosis and monitoring UMCN 1.4: Immunotherapy, gene therapy and transplantation UMCN 1.5: Interventional oncology |
| Organization: | Haematology Blood Transfusion and Transplantation Immunology CHL Radiation Oncology |
| Appears in Collections: | Academic bibliography
|
|
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2066/57804
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
|